Patent details

Basic Information

Publication number:

EP1440709

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP040104366

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Combinations comprising cGMP PDE5 inhibitors.

French Title of Invention:

Combinaisons comprenant des inhibiteurs de cGMP PDE5.

German Title of Invention:

Kombinationen enthaltend cGMP-PDE5-hemmer.

SPC Number:

Dates

Filing date:

17/10/2000

Grant date:

05/12/2007

EP Publication Date:

05/12/2007

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

28/07/2004

EP B1 Publication Date:

05/12/2007

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

17/10/2009

Expiration date:

17/10/2020

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

17/10/2000

 

 

Name:

PFIZER INC.

Address:

235 East 42nd Street, New York, N.Y. 10017, United States (US)

Name:

Pfizer Limited

Address:

Ramsgate Road, Sandwich, Kent CT13 9NJ, United Kingdom (GB)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

05/12/2007

Address:

PO Box 48, 8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

Koppiker Nandan Parmanand

Address:

United Kingdom (GB)

2

Name:

Forster Eliot Richard

Address:

United Kingdom (GB)

Priority

1

Priority Number:

9924958

Priority Date:

21/10/1999

Priority Country:

United Kingdom (GB)

2

Priority Number:

0021520

Priority Date:

01/09/2000

Priority Country:

United Kingdom (GB)

Classification

Main IPC Class:

A61P 25/02;

Filing date	Document type	Number of pages